Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1833991000168118 | asfotase alfa 12 mg / 0.3 mL injection, 0.3 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1834001000168114 | asfotase alfa 12 mg/0.3 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| asfotase alfa 12 mg/0.3 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| asfotase alfa 12 mg/0.3 mL injection, vial | Is a | asfotase alfa | true | Inferred relationship | Some | ||
| asfotase alfa 12 mg/0.3 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| asfotase alfa 12 mg/0.3 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1206713105 | |
| asfotase alfa 12 mg/0.3 mL injection, vial | has Australian BoSS | asfotase alfa | true | Inferred relationship | Some | 1206713104 | |
| asfotase alfa 12 mg/0.3 mL injection, vial | has intended active ingredient | asfotase alfa | true | Inferred relationship | Some | 1206713104 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| asfotase alfa 12 mg/0.3 mL injection, 0.3 mL vial | has MPUU | True | asfotase alfa 12 mg/0.3 mL injection, vial | Inferred relationship | Some | 1 |
| Strensiq 12 mg/0.3 mL injection, 0.3 mL vial | Is a | True | asfotase alfa 12 mg/0.3 mL injection, vial | Inferred relationship | Some | |
| asfotase alfa 12 mg/0.3 mL injection, 12 x 0.3 mL vials | has MPUU | True | asfotase alfa 12 mg/0.3 mL injection, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR